Significantly more patients with valacyclovir prophylaxis developed biopsy-proven acute rejection ( 18 of 59 [ 31 % ] versus 10 of 60 [ 17 % ] ; adjusted hazard ratio , 2.49 ; 95 % confidence interval , 1.09 to 5.65 ; P = 0.03 ) .